Table 1.
Number (%) or median (mean ± SD) | |
---|---|
Age (years) | 66 (66.0 ± 5.95) |
Initial PSA (ng/mL) | 8.5 (11.0 ± 6.5) |
NCCN risk criteria | |
Low | 10 (13.7%) |
Intermediate | 35 (47.9%) |
High | 28 (38.4%) |
NLR | 1.85 (2.20 ± 1.04) |
Gleason score | |
≤6 | 12 (16.4%) |
7 | 51 (69.8%) |
≥8 | 10 (13.7%) |
Pathological T stage | |
2 | 51 (69.9%) |
3 | 21 (28.8%) |
4 | 1 (1.4%) |
Lymph node metastasis | 5 (6.8%) |
Positive resection margin | 27 (37.0%) |
PSA failure | 15 (20.5%) |
Observation period | 20.7 (25.9 ± 20.8) |